River Road Asset Management LLC lowered its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 11.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 209,367 shares of the pharmacy operator’s stock after selling 28,385 shares during the quarter. River Road Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $11,015,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of WBA. Stonebridge Capital Advisors LLC purchased a new position in Walgreens Boots Alliance during the first quarter worth approximately $27,000. Loomis Sayles & Co. L P purchased a new position in shares of Walgreens Boots Alliance in the first quarter valued at approximately $33,000. Red Door Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance in the second quarter valued at approximately $35,000. Glassman Wealth Services lifted its position in shares of Walgreens Boots Alliance by 181.8% in the first quarter. Glassman Wealth Services now owns 651 shares of the pharmacy operator’s stock valued at $36,000 after acquiring an additional 420 shares in the last quarter. Finally, Centerpoint Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 203.8% in the second quarter. Centerpoint Advisors LLC now owns 711 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 477 shares in the last quarter. Institutional investors own 55.65% of the company’s stock.
Several equities analysts have recently weighed in on WBA shares. Evercore ISI restated a “hold” rating and issued a $52.00 target price on shares of Walgreens Boots Alliance in a research report on Friday, July 2nd. Barclays reduced their price objective on Walgreens Boots Alliance from $55.00 to $53.00 and set an “equal weight” rating on the stock in a research report on Tuesday, July 6th. Truist Securities reduced their price objective on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a research report on Friday, July 2nd. Credit Suisse Group reduced their price objective on Walgreens Boots Alliance from $50.00 to $48.00 and set a “neutral” rating on the stock in a research report on Friday, July 2nd. Finally, TheStreet downgraded Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research report on Friday, June 18th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $50.83.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, June 30th. The pharmacy operator reported $1.38 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.17 by $0.21. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The business had revenue of $34.03 billion during the quarter, compared to analysts’ expectations of $33.47 billion. During the same period in the previous year, the firm posted $0.71 earnings per share. The company’s revenue was up 12.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.75 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 10th. Stockholders of record on Friday, August 20th were paid a $0.477 dividend. The ex-dividend date of this dividend was Thursday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. This represents a $1.91 dividend on an annualized basis and a dividend yield of 3.96%. Walgreens Boots Alliance’s payout ratio is presently 40.30%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.
Read More: How to start trading in the forex market?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.